Lung Cancers Unknown Status Phase 3 Trials for Paclitaxel (DB01229)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Unknown Status3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00551733Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerTreatment
NCT00077220Paclitaxel, Carboplatin, and Radiation Therapy With or Without Adjuvant Paclitaxel and Carboplatin in Treating Patients With Stage II or Stage III Unresectable Non-Small Cell Lung CancerTreatment
NCT00039039Combination Chemotherapy Followed by Radiation Therapy With or Without Paclitaxel in Treating Patients With Unresectable Stage III Non-Small Cell Lung CancerTreatment
NCT00054210Polyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung CancerTreatment
NCT00011921Chemotherapy Followed by Peripheral Stem Cell or Bone Marrow Transplant Compared With Chemotherapy Alone in Treating Patients With Small Cell Lung CancerTreatment
NCT00006049ZD 1839 Plus Chemotherapy in Treating Patients With Non-Small Cell Lung CancerTreatment
NCT00004887Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer That Cannot Be Removed During SurgeryTreatment
NCT00003696Combination Chemotherapy in Treating Patients Who Have Extensive-Stage Small Cell Lung CancerTreatment